Stereotactic body radiation therapy for early-stage lung cancer

Genevieve Maquilan, Robert Timmerman

Research output: Contribution to journalReview article

8 Scopus citations

Abstract

Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy, is a technique of external beam radiation that delivers precisely targeted, ablative doses to extracranial sites. It has become an integral component of the management of early-stage non-small cell lung cancer (NSCLC). In this review, we discuss the technology and techniques used in treatment planning and delivery, the efficacy and toxicity of SBRT for medically inoperable early-stage NSCLC, and the preliminary investigations into the role of SBRT for operable early-stage NSCLC.

Original languageEnglish (US)
Pages (from-to)274-279
Number of pages6
JournalCancer Journal (United States)
Volume22
Issue number4
DOIs
StatePublished - Jul 26 2016

Keywords

  • Non-small cell lung cancer
  • Stereotactic ablative radiotherapy
  • Stereotactic body radiation therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Stereotactic body radiation therapy for early-stage lung cancer'. Together they form a unique fingerprint.

  • Cite this